EQRx

About:

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Website: https://www.eqrx.com

Twitter/X: EQRXINC

Top Investors: Andreessen Horowitz, Google Ventures, Fidelity, Verily, ARCH Venture Partners

Description:

EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.

Total Funding Amount:

$1.9B

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)EQRx.com

Hub Tags:

Exited Unicorn

Founders:

Alexis Borisy, Melanie Nallicheri, Peter Bach, Sandra Horning

Number of Employees:

251-500

Last Funding Date:

2021-12-17

IPO Status:

Public

© 2025 bioDAO.ai